ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 30th, 2018 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 30th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of March 21, 2018, is entered into between Ascendance Biotechnology, Inc., a Delaware corporation (the “Company”), and AgeX Therapeutics, Inc., a Delaware corporation (“Buyer”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 19th, 2018 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 19th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of March 21, 2018, is entered into between Ascendance Biotechnology, Inc., a Delaware corporation (the “Company”), and AgeX Therapeutics, Inc., a Delaware corporation (“Buyer”).